Probiotics and Irritable Bowel Syndrome (IBS): Evidence Update and Practical Considerations for Primary Care
Dr Dave Chatoor is a Neurogastro Surgeon at University College London Hospitals NHS Foundation Trust in London, U.K. In this webinar, Dr Dave Chatoor delivers a summary of the current management guidelines for irritable bowel syndrome (IBS), including an overview of the potential of specific probiotic strains including Bifidobacterium longum 35624™ and Bifidobacterium longum 1714™. Dr Chatoor discusses the latest research, alongside reflections of his own clinical experience with individuals with IBS, including practical tips for communicating with individuals regarding their symptoms and management approaches.
Learning Objectives:
1. Understand why IBS has been reclassified as a disorder of gut-brain interaction and the implications for its management in clinical settings2. Understand the latest clinical and real world evidence available regarding the use of specific probiotic strains (with a focus upon Bifidobacterium longum strains 35624® and 1714®) as part of the clinical management of IBS symptoms3. Understand how to effectively communicate with individuals with IBS symptoms regarding their symptoms and management planRecommended for you…
CPD e-learning
0.5 CPD learning hour
CPD e-learning
1 CPD learning hour
Webinar on Demand
0.5 CPD learning hour
Clinical Summary
~5 minute read